1. Home
  2. ELOG vs MBRX Comparison

ELOG vs MBRX Comparison

Compare ELOG & MBRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Eastern International Ltd. Ordinary Shares

ELOG

Eastern International Ltd. Ordinary Shares

N/A

Current Price

$0.70

Market Cap

6.4M

Sector

Industrials

ML Signal

N/A

Logo Moleculin Biotech Inc.

MBRX

Moleculin Biotech Inc.

N/A

Current Price

$8.73

Market Cap

6.4M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
ELOG
MBRX
Founded
2006
2015
Country
China
United States
Employees
N/A
N/A
Industry
Integrated Freight & Logistics
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.4M
6.4M
IPO Year
2024
2016

Fundamental Metrics

Financial Performance
Metric
ELOG
MBRX
Price
$0.70
$8.73
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
★ $240.00
AVG Volume (30 Days)
★ 647.9K
206.0K
Earning Date
11-19-2026
11-20-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$6.84
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.40
$0.16
52 Week High
$2.83
$12.65

Technical Indicators

Market Signals
Indicator
ELOG
MBRX
Relative Strength Index (RSI) 37.38 80.14
Support Level $0.42 $2.12
Resistance Level $1.01 $10.24
Average True Range (ATR) 0.11 0.99
MACD -0.05 0.16
Stochastic Oscillator 2.62 72.00

Price Performance

Historical Comparison
ELOG
MBRX

About ELOG Eastern International Ltd. Ordinary Shares

Eastern International Ltd is a holding company. The company operates through its subsidiary engaged in domestic and cross-border professional logistic services including project logistics and general logistics for company clients. Its project logistic services include Construction project logistics and special cargo logistics for large or precision equipment and General logistic services refer to the transportation, warehousing, loading and unloading, and distribution of ordinary products.

About MBRX Moleculin Biotech Inc.

Moleculin Biotech Inc is a late-stage pharmaceutical development company currently evaluating Annamycin, also known as L-Annamycin and by its generic name naxtarubicin. The company has two additional portfolios of technologies for hard-to-treat cancers and viruses with clinical and preclinical research funded by investigators at academic institutions. The Company operates in one reportable segment, which is the development and commercialization of drug products.

Share on Social Networks: